Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Multicenter Cohort Study) III

NCT04918108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-11-20

No results posted yet for this study

Summary

Anatomopathological classifications have been well identified in aortic dissection with important therapeutic implications. The authors evaluated the inflammatory response in patients with aortic dissection (AD) and assessed the presence of distinct inflammatory subphenotypes within this disease.

Conditions

  • Aortic Dissection

Interventions

BIOLOGICAL

inflammatory response

laboratory data (leukocyte, neutrophils, monocyte, lymphocytes, platelet, fibrinogen, D-dimer, neutrophils-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio)

Sponsors & Collaborators

  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • The Affiliated Hospital of Qingdao University

    collaborator OTHER
  • First Affiliated Hospital of Shantou University Medical College

    collaborator OTHER
  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • TEDA International Cardiovascular Hospital

    collaborator OTHER
  • Xiamen Cardiovascular Hospital

    collaborator UNKNOWN
  • Shanghai East Hospital Tongji University

    collaborator UNKNOWN
  • Tianjin Chest Hospital, Tianjin Medical University

    collaborator UNKNOWN
  • Nanjing First Hospital, Nanjing Medical University

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • The First Affiliated Hospital of Bengbu Medical University

    collaborator OTHER
  • Nanjing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04918108 on ClinicalTrials.gov